Alphatec Holdings, Inc. (ATEC) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-02-24

How it makes money

It earns revenue by selling spinal surgery implants and medical imaging equipment to hospitals and surgical centers.

Hospitals and surgical centers purchase spinal implants, such as pedicle screws, interbody devices, plates, and tissue-based materials, alongside EOS full-body and weight-bearing x-ray imaging devices. Sales are driven primarily by increasing surgeon adoption of proprietary approach-specific procedures that integrate specialized hardware with software platforms.

What protects it: the moat

It protects its market position through proprietary software platforms, integrated surgical approaches, and extensive intellectual property portfolios.

Management claims that specialized technology platforms like InformatiX and EOS Insight, combined with approach-specific portfolios and nerve-monitoring systems, create a differentiated ecosystem that builds surgeon loyalty and clinical distinction. Competitors include large medical device companies with greater resources for research, development, and patent litigation.

What growth costs

It incurs ongoing costs for product design, regulatory compliance, sales network expansion, and financing servicing.

Reinvestment requires funding in-house product design, clinical data collection, patent litigation, and the recruitment or retention of independent sales agents. Additionally, it must service obligations from its $405.0 million principal amount of unsecured senior convertible notes due 2030, which bear a stated interest rate of 0.75%.

What could damage it

If third-party payers deny coverage or reduce reimbursement for procedures using its products, hospital demand and company revenues would decline.

Hospitals rely on adequate coverage and reimbursement from third-party payers, principally Medicare, Medicaid and private health insurance plans, to purchase surgical implants and imaging equipment. If payers alter coverage policies or deny reimbursement for outpatient procedures utilizing its technology, customer demand drops and financial results are adversely affected.

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Other companies in Medical Devices